Is the SPINK1 variant p.N34S overrepresented in patients with acute pancreatitis?

Maiken Thyregod Jøergensen, Klaus Brusgaard, Srdan Novovic, Anders Møller Andersen, Mark Berner Hansen, Anne-Marie Gerdes, Ove Bent Schaffalitzky de Muckadell

6 Citationer (Scopus)

Abstract

Serine Protease Inhibitor Kazal type 1 (SPINK1) protects against premature intracellular activation of trypsinogen and development of acute pancreatitis. Our aim was to determine the prevalence of SPINK1 mutations (a) in unselected patients with first-time acute pancreatitis and (b) in the Danish background population (c) in a meta-analysis to combine the results with findings in similar investigations worldwide and (d) to evaluate whether patients with SPINK1 mutations had a more severe clinical course.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Gastroenterology and Hepatology
Vol/bind24
Udgave nummer3
Sider (fra-til)309-15
Antal sider7
ISSN0954-691X
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Is the SPINK1 variant p.N34S overrepresented in patients with acute pancreatitis?'. Sammen danner de et unikt fingeraftryk.

Citationsformater